Published in Enferm Infecc Microbiol Clin on May 01, 2000
Viruses and multiple sclerosis. CNS Neurol Disord Drug Targets (2012) 1.15
Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production. Eur J Clin Microbiol Infect Dis (2010) 0.95
Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis. PLoS One (2014) 0.79
The High Prevalence of the Varicella Zoster Virus in Patients With Relapsing-Remitting Multiple Sclerosis: A Case-Control Study in the North of Iran. Jundishapur J Microbiol (2016) 0.75
Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis (1999) 2.81
[Antimicrobial therapy in exacerbated chronic obstructive pulmonary disease]. Arch Bronconeumol (2002) 2.03
Quality of life among stroke survivors evaluated 1 year after stroke: experience of a stroke unit. Stroke (2000) 1.75
STAT3 locus in inflammatory bowel disease and multiple sclerosis susceptibility. Genes Immun (2010) 1.66
Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA. J Hosp Infect (1997) 1.64
Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis (1995) 1.64
The regulation by iron of the synthesis of adhesins and cytoadherence levels in the protozoan Trichomonas vaginalis. J Exp Med (1991) 1.53
[Direct cost of cerebrovascular disease during the first year of follow-up]. Rev Neurol (1999) 1.44
Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae. Clin Infect Dis (1994) 1.44
Neutralizing antibodies, MxA expression and MMP-9/TIMP-1 ratio as markers of bioavailability of interferon-beta treatment in multiple sclerosis patients: a two-year follow-up study. Eur J Neurol (2009) 1.44
[Cytomegalovirus: comparative study of diagnostic techniques]. Enferm Infecc Microbiol Clin (1998) 1.42
Clinical scores and patient risk stratification in non-ST elevation acute coronary syndrome. Int J Cardiol (2010) 1.41
[Human papillomavirus vaccines: a new challenge for pediatricians]. An Pediatr (Barc) (2006) 1.40
[The return of gram-positive bacteria]. Enferm Infecc Microbiol Clin (1993) 1.38
[The psychometric properties of the Spanish version of the stroke-adapted 30-item Sickness Impact Profile (SIP30-AI)]. Rev Neurol (2007) 1.38
[Comparative study of pneumococcal bacteremia in patients with and without HIV infection]. Rev Clin Esp (1993) 1.36
Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae. Antimicrob Agents Chemother (2003) 1.34
Cloning and molecular characterization of two genes encoding adhesion proteins involved in Trichomonas vaginalis cytoadherence. Mol Microbiol (1995) 1.33
[Use of antibiotics in exacerbated chronic obstructive pulmonary disease]. Aten Primaria (2001) 1.31
Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci. Antimicrob Agents Chemother (2000) 1.28
Specific parasitism of purified vaginal epithelial cells by Trichomonas vaginalis. Infect Immun (1988) 1.28
Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci. Antimicrob Agents Chemother (1994) 1.27
Association of the STAT4 gene with increased susceptibility for some immune-mediated diseases. Arthritis Rheum (2008) 1.26
Specificities of antibodies to native DNA. Scand J Rheumatol Suppl (1975) 1.24
Middle cerebral artery embolism and unilateral visual loss after autologous fat injection into the glabellar area. Stroke (1993) 1.23
The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis. Genes Immun (2010) 1.22
The central nervous system and infection by Candida species. Diagn Microbiol Infect Dis (2000) 1.17
Entamoeba histolytica : a novel cysteine protease and an adhesin form the 112 kDa surface protein. Mol Microbiol (1999) 1.17
Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agents. Antimicrob Agents Chemother (1999) 1.12
CP30, a cysteine proteinase involved in Trichomonas vaginalis cytoadherence. Infect Immun (2000) 1.12
Comparison of epidemiological markers of Salmonella strains isolated from different sources in Spain. J Clin Microbiol (1992) 1.10
Antibiotic resistance surveillance of Stenotrophomonas maltophilia, 1993-1999. J Antimicrob Chemother (2001) 1.10
Serodiagnosis of typhoid fever in paediatric patients by anti-LPS ELISA. Trans R Soc Trop Med Hyg (1987) 1.09
Localization and identification of an Entamoeba histolytica adhesin. Mol Biochem Parasitol (1987) 1.07
A novel cysteine proteinase (CP65) of Trichomonas vaginalis involved in cytotoxicity. Microb Pathog (2000) 1.07
Antibiotic susceptibility of group A streptococci: a 6-year follow-up study. Antimicrob Agents Chemother (1993) 1.06
Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients. Mult Scler (2008) 1.01
Chromosomal region 16p13: further evidence of increased predisposition to immune diseases. Ann Rheum Dis (2010) 1.01
Susceptibility to multiple sclerosis mediated by HLA-DRB1 is influenced by a second gene telomeric of the TNF cluster. Hum Immunol (1999) 1.00
Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis. Neurology (1999) 1.00
Trypanosoma evansi infection in mainland Spain. Vet Parasitol (2009) 0.98
Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989. Eur J Clin Microbiol Infect Dis (1992) 0.97
Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer's disease and neurological disorders. Methods Find Exp Clin Pharmacol (1991) 0.97
IL23R: a susceptibility locus for celiac disease and multiple sclerosis? Genes Immun (2008) 0.97
Small scale frying of potatoes in sunflower oil: thermooxidative alteration of the fat content in the fried product. Z Ernahrungswiss (1994) 0.96
Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient. Clin Microbiol Infect (2011) 0.96
In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae: mechanisms of macrolide and tetracycline resistance. Antimicrob Agents Chemother (2004) 0.95
Endophthalmitis caused by Listeria monocytogenes. J Clin Microbiol (2001) 0.95
A cytokine gene screen uncovers SOCS1 as genetic risk factor for multiple sclerosis. Genes Immun (2011) 0.94
In vitro activity of tigecycline against Bacteroides species. J Antimicrob Chemother (2005) 0.93
Effect of BSN-MST1 locus on inflammatory bowel disease and multiple sclerosis susceptibility. Genes Immun (2009) 0.92
[Incidence of invasive pneumococcal infection in children aged less than two years. The heptavalent pneumococcal conjugate vaccine. Situation in Spain]. An Esp Pediatr (2002) 0.92
Corticosteroids, ibuprofen, and acetaminophen for IFNbeta-1a flu symptoms in MS: a randomized trial. Neurology (2004) 0.92
Impact of the BACTEC NR system in detecting Candida fungemia. J Clin Microbiol (1990) 0.91
Predominance of gram-positive microorganisms as a cause of septicemia in patients with hematological malignancies. Infect Control Hosp Epidemiol (1994) 0.91
Aminoglycoside-modifying enzymes in clinical isolates harboring extended-spectrum beta-lactamases. Antimicrob Agents Chemother (1992) 0.91
Alien hand sign or alien hand syndrome? J Neurol Neurosurg Psychiatry (1995) 0.91
Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents. Antimicrob Agents Chemother (1990) 0.89
ANKRD55 and DHCR7 are novel multiple sclerosis risk loci. Genes Immun (2011) 0.89
Natalizumab treatment of multiple sclerosis in Spain: results of an extensive observational study. J Neurol (2012) 0.88
In vitro activity of retapamulin against linezolid and methicillin-resistant Staphylococcus aureus isolates. Rev Esp Quimioter (2011) 0.88
[Immunization schedule of the Spanish Association of Pediatrics: recommendations 2008]. An Pediatr (Barc) (2008) 0.88
Carotid body tumor: unusual cause of transient ischemic attacks. Stroke (1988) 0.88
High incidence of severe infections in heart transplant recipients receiving tacrolimus. Transplant Proc (2003) 0.87
Spontaneous cervical epidural hematoma with Brown-Séquard syndrome and spontaneous resolution. Case report. J Neurosurg Sci (1993) 0.87
Interferon-beta treatment and active replication of the JC virus in relapsing-remitting multiple sclerosis patients. Eur J Neurol (2007) 0.87
YIGSR is the preferential laminin-1 residing adhesion sequence for Trichomonas vaginalis. Exp Parasitol (1998) 0.86
Incidence of erythromycin resistance in Streptococcus pyogenes: a 10-year study. Diagn Microbiol Infect Dis (1999) 0.86
Human herpesvirus 6 and effectiveness of interferon β1b in multiple sclerosis patients. Eur J Neurol (2011) 0.86
Responsiveness of Trichomonas vaginalis to iron concentrations: evidence for a post-transcriptional iron regulation by an IRE/IRP-like system. Infect Genet Evol (2009) 0.85
Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis. J Neuroimmunol (1997) 0.85
MHC2TA rs4774C and HHV-6A active replication in multiple sclerosis patients. Eur J Neurol (2009) 0.85
[Bacteremia by Staphylococcus aureus: analysis of 311 episodes]. Enferm Infecc Microbiol Clin (1999) 0.85
Hypoxia induces major effects on cell cycle kinetics and protein expression in Drosophila melanogaster embryos. Am J Physiol Regul Integr Comp Physiol (2004) 0.84
Replication of top markers of a genome-wide association study in multiple sclerosis in Spain. Genes Immun (2010) 0.84
Autoantibodies to cryptic epitopes of C-reactive protein and other acute phase proteins in the toxic oil syndrome. J Autoimmun (1995) 0.84
Tuberculous meningitis. Clinical characteristics and comparison with cryptococcal meningitis in patients with human immunodeficiency virus infection. Arch Neurol (1996) 0.83
Comparative activity of linezolid and other new agents against methicillin-resistant Staphylococcus aureus and teicoplanin-intermediate coagulase-negative staphylococci. J Antimicrob Chemother (2001) 0.83
Distribution of mef(A) and erm(B) genes in macrolide-resistant blood isolates of viridans group streptococci. J Antimicrob Chemother (2001) 0.83
May intracranial hypotension be a cause of venous sinus thrombosis? Eur Neurol (2004) 0.82
The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain. Mult Scler (2009) 0.82
[Pentastomiasis in Costa Rica caused by Linguatula serrata and its differential diagnosis from L. recurvata]. Rev Latinoam Microbiol (1987) 0.82
Cerebrospinal fluid anti-cardiolipin antibodies in patients with HIV-1 infection. J Acquir Immune Defic Syndr (1991) 0.82
Glypican 5 is an interferon-beta response gene: a replication study. Mult Scler (2009) 0.81
A new implant designed to maximize contact with trabecular bone: survival to 18 months. J Oral Implantol (2001) 0.81
In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents. J Antimicrob Chemother (1999) 0.81
Peritonitis caused by Haemophilus parainfluenzae in a patient undergoing continuous ambulatory peritoneal dialysis. J Clin Microbiol (1999) 0.81
[1st Spanish epidemic of plasmid resistance to 3d generation cephalosporins: the implication of SHV-2]. Enferm Infecc Microbiol Clin (1992) 0.81
Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon beta therapy and human herpes virus-6 infection. Genes Immun (2010) 0.81
New model for microsurgical training and skills maintenance. Microsurgery (1995) 0.80
Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis. Mult Scler (2011) 0.80
Identification of two novel Trichomonas vaginalis eif-5a genes. Infect Genet Evol (2010) 0.80
Activity of doripenem against extended-spectrum beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa isolates. Eur J Clin Microbiol Infect Dis (2010) 0.80
[Community-acquired respiratory infections]. Enferm Infecc Microbiol Clin (1997) 0.80
Penicillin tolerance of group A streptococci. Eur J Clin Microbiol Infect Dis (1989) 0.80
TNF-376A marks susceptibility to MS in the Spanish population: A replication study. Neurology (2004) 0.80
Differences between coding and non-coding regions in the Trichomonas vaginalis genome: an actin gene as a locus model(1). Acta Trop (2001) 0.79